Basic Information
Basic information for MIR646HG-229-47aa
Peptide Name MIR646HG-229-47aa
Genome Position chr20:60125974-60126114[+]
Species Human
Peptide Sequence MGVLPGNQETGEACWNLLRNPSLQQETDGGLQGPGRCRKPLLLQEKG
Peptide Length 47
Unique No (MIR646HG-213-47aa,MIR646HG-215-47aa,MIR646HG-217-47aa,MIR646HG-222-47aa,MIR646HG-234-47aa,MIR646HG-246-47aa,MIR646HG-253-47aa,MIR646HG-254-47aa)
Grand Average of Hydropathicity -0.7702
Relative Molecular Mass 5919.55
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000656658;MIR646HG-229
Transcript Length 1502
Coding Ability 0.3123
DNA Sequence Corresponding to Peptide ATGGGGGTGCTGCCTGGAAATCAGGAAACTGGAGAAGCCTGCTGGAACCTGCTGAGGAACCCATCACTGCAGCAAGAGACTGATGGTGGACTGCAGGGGCCAGGAAGGTGCAGGAAGCCCCTGCTGCTGCAGGAGAAAGGA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :